Hojjat Naderi-Meshkin

Dr. Hojjat Naderi-Meshkin is a Research Fellow affiliated with the Wellcome Wolfson Institute for Experimental Medicine within the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast. His research bridges stem cell biology, vascular pathophysiology, and diabetic complications, focusing on organoid-based disease modeling and regenerative therapies.

Research interests center on:

• Mechanisms of endothelial dysfunction in diabetes
• Angiogenic repair using stem cell-derived approaches
• Development of vascular organoids for disease modeling
• Extracellular matrix remodeling in tissue regeneration
• Hypoxia-responsive signaling pathways in vascular cells

Recent publications demonstrate strong emphasis on diabetic vasculopathy, with 2023-2024 studies examining NOX4 signaling in hypoxia, cellular heterogeneity in vascular organoids, and amniotic membrane applications in wound healing. Collaborative work frequently involves multi-omics approaches and patient-derived models.

Laboratory activities focus on advanced cell culture systems including induced pluripotent stem cells and 3D organoid platforms to investigate therapeutic strategies for vascular complications.